单孔机器人辅助根治性前列腺切除术的并发症:单孔先进研究联盟(SPARC)多机构分析
基于SPARC多机构前瞻性维护数据库的回顾性分析,纳入2019至2022年接受三种入路单孔机器人辅助根治性前列腺切除术的1103例患者,评估围手术期并发症与90天再入院。结果显示术中并发症0.4%,术后并发症13%,主要并发症(Clavien-Dindo≥III级)3.7%,90天再入院率3.9%,作者认为该术式安全有效且并发症与再入院率低,与现有多孔RARP文献相当。
要点
- 术中并发症5例(0.4%),均发生于经腹腔入路。
- 术后并发症143例(13%),主要并发症(Clavien-Dindo≥III级)仅占3.7%。
- 最常见并发症为淋巴囊肿(3.9%)、急性尿潴留(2%)和尿路感染(1.9%)。
核心结论
- 单孔机器人辅助根治性前列腺切除术无论采用何种入路均为安全有效的手术,并发症率和再入院率低,结果与现有多孔RARP文献相当。
研究设计与样本
- 对前瞻性维护、经机构审查委员会批准的多机构SPARC数据库进行回顾性审查,共识别2019至2022年间使用专用单孔机器人平台接受三种不同入路SP-RARP的1103例患者。
主要发现
- 经腹腔、经腹膜外和经膀胱SP-RARP分别有244例、712例和147例患者,术中并发症见于5例(0.4%),均发生于经腹腔入路。
- 2例发生肠浆膜撕裂,2例发生膀胱后壁穿刺伤需修补,1例发生闭孔神经损伤。
- 术后并发症见于143例(13%),主要并发症(Clavien-Dindo≥III级)仅占全部队列的3.7%。
- 最常见并发症为淋巴囊肿(3.9%)、急性尿潴留(2%)和尿路感染(1.9%)。
- 90天再入院率为3.9%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the perioperative complications of single-port robot-assisted radical prostatectomy (SP-RARP). PATIENTS AND METHODS: A retrospective review was performed on the prospectively maintained, Institutional Review Board-approved, multi-institutional Single-Port Advanced Research Consortium (SPARC) database. A total of 1103 patients were identified who underwent three different approaches of SP-RARP between 2019 and 2022 using the purpose-built SP robotic platform. In addition to baseline clinical, perioperative outcomes, this study comprehensively analysed for any evidence of intraoperative complication, as well as postoperative complication and readmission within 90 days of the respective surgery. RESULTS: Of the 244, 712, and 147 patients who underwent transperitoneal, extraperitoneal, and transvesical SP-RARP, respectively, intraoperative complications were noted in five patients (0.4%), all of which occurred during the transperitoneal approach. Two patients had bowel serosal tears, two had posterior button-holing of the bladder necessitating repair, and one patient had an obturator nerve injury. Postoperative complications were noted in 143 patients (13%) with major complications (Clavien-Dindo Grade ≥III) only identified in 3.7% of the total cohort. The most common complications were lymphocele (3.9%), acute urinary retention (2%), and urinary tract infection (1.9%). The 90-day re-admission rate was 3.9%. CONCLUSION: The SP-RARP is a safe and effective procedure with low complication and readmission rates regardless of the approach. These results are comparable to current multi-port RARP literature.
引用
- Soputro NA, Chavali JS, Ferguson EL, et al. Complications of single-port robot-assisted radical prostatectomy: multi-institutional analysis from the Single-Port Advanced Research Consortium (SPARC). BJU Int. 2023. PMID: 37971182. doi:10.1111/bju.16228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。